Jacob Adashek, DO @jacobadashek @USouthFlorida @MoffittNews @Dr_R_Kurzrock @AlexeyGoloubev #SITC20 #carcinomas Immunotherapy trials lack a biomarker for inclusion: implications for drug d...

Jacob Adashek, DO @jacobadashek @USouthFlorida @MoffittNews @Dr_R_Kurzrock @AlexeyGoloubev #SITC20 #carcinomas Immunotherapy trials lack a biomarker for inclusion: implications for drug d...

User Photo
SITC

2 weeks
38 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:

Jacob Adashek, DO of The University of South Florida and H. Lee Moffitt Cancer Center & Research Institute discusses the Poster Presentation Immunotherapy trials lack a biomarker for inclusion: implications for drug development.


Poster Presentation #179

Immunotherapy research lacks a biomarker for inclusion: drug discovery implications.

Co-Authored by Alexey Goloubev; Shumei Kato, MD; Razelle Kurzrock, MD.

Up Next Autoplay
>